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Comfrey or Symphytum officinale (L.) (Boraginaceae) is a very popular plant used for
therapeutic purposes. Since the 1980s, its effects have been studied in long-term carcinogenesis
studies, in which Comfrey extract is administered at high doses during several months and the
neoplastic hepatic lesions are evaluated. However, the literature on this topic is very poor
considering the studies performed under short-term carcinogenesis protocols, such as the
‘resistant hepatocyte model’ (RHM). In these studies, it is possible to observe easily the
phenomena related to the early phases of tumor development, since pre-neoplastic lesions
(PNLs) rise in about 1–2 months of chemical induction. Herein, the effects of chronic oral
treatment of rats with 10% Comfrey ethanolic extract were evaluated in a RHM. Wistar rats
were sequentially treated with N-nitrosodiethylamine (ip) and 2-acetilaminofluorene (po), and
submitted to hepatectomy to induce carcinogenesis promotion. Macroscopic/microscopic
quantitative analysis of PNL was performed. Non-parametric statistical tests (Mann–Whitney
and 
2) were used, and the level of significance was set at P0.05. Comfrey treatment reduced
the number of pre-neoplastic macroscopic lesions up to 1mm (P0.05), the percentage of oval
cells (P=0.0001) and mitotic figures (P=0.007), as well as the number of Proliferating Cell
Nuclear Antigen (PCNA) positive cells (P=0.0001) and acidophilic pre-neoplastic nodules
(P=0.05). On the other hand, the percentage of cells presenting megalocytosis (P=0.0001)
and vacuolar degeneration (P=0.0001) was increased. Scores of fibrosis, glycogen stores and
the number of nucleolus organizing regions were not altered. The study indicated that oral
treatment of rats with 10% Comfrey alcoholic extract reduced cell proliferation in this model.
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Introduction
The systematic study of plants normally used for
consumption and that are able to modify the carcinogen-
esis process has greatly developed over recent years (1–6).
Comfrey or Symphytum officinale (L.) (Boraginaceae)i s
a plant of fast growth, whose leaves and roots are used
therapeutically since the XVI century, especially to
improve wound healing. Since the 1930s it has been
used for animal feed, but this use has been prohibited in
Australia and New Zealand (5,7).
The toxic effects of Comfrey were described in the early
1980s and, since then, various pyrrolizidine alkaloids, such
as lasiocarpine, lycopsamine, intermedine, symlandine,
riddelliine and mainly symphytine have been identified
(8–13). Chou and Fu (14) have recently determined
that metabolic products of pyrrolizidine alkaloids, such
as6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine
(DHP)-derived DNA adducts, are formed in the liver of
female F344 rats and can be related to its toxic effects.
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properly cited.In long-term protocols, it was demonstrated that these
active principles were hepatotoxic, mutagenic and carci-
nogenic (15). Mei and colleagues (16) observed that
dietary comfrey resulted in marked changes in liver gene
expression, body weight and mutation frequency. Hirono
and colleagues (17) demonstrated that pyrrolizidine
alkaloids induced hepatocellular adenoma and heman-
giosarcoma with lung metastasis. Also, severe venous-
occlusive disease was present in the liver, characterized by
hepatocyte swelling, formation of membrane blebs,
endothelial proliferation and peri-venular hemorrhagic
necrosis with deposition of reticulin (18,19). Liver disease
was also identified in cases of human chronic intoxication
(20,21), although some aspects of human toxicity of
Comfrey has been recently revisited (22).
Among several demonstrations of carcinogenic effects
of Comfrey, few studies have reported its anti-neoplastic
effects (23). Even though, current information about its
action in the initial stages of the carcinogenic process—
that could be easily evidenced in short-term protocols—is
very poor. Also, most studies of short-term hepatic
carcinogenesis were performed using isolated active
principles (15,24).
Experimental models of liver carcinogenesis represent
a simple and frequently used method for studying
the genesis and evolution of neoplasms, because of
the size and susceptibility of this organ to cancer
(25,26). Likewise, these short-term models—hepatectomy
with treatment of animals with carcinogenic substances—
are fast to perform, and rigid control of experimental
conditions can be achieved without lack the in vivo
particularities of carcinogenesis (27). The model used in
the present work, resistant hepatocyte model (RHM),
was first described by Solf and Faber (28). Thus, a single
dose of N-nitrosodiethylamine (DEN) and repeated low
doses of 2-acetilaminofluorene (AAF), both initiator
agents, are administered concomitantly with hepatec-
tomy, which acts as promotion stimulus. In this model,
pre-neoplastic lesions (PNLs) can be seen in the liver as
early as 5–10 days after hepatectomy. In the contrary, in
long-term models, the prolonged treatment with carcino-
gens without surgery requires much more time to obtain
the same lesions.
Herein, this model was used to study the effects of
Comfrey extract on the development of early PNLs
in liver.
Methods
Animals
Adult male Wistar rats weighting 200–250g were used.
They were kept in conventional plastic cages (maximum:
five rats per cage) maintained in an exclusive room and
were exposed to a controlled light cycle (lights on from
6:30 AM to 6:30 PM) and temperature, which was fixed
at 222C. Food and drink were offered ad libitum. All
animal care and maintenance procedures were performed
according to guidelines of BPL (Brazilian GLP).
Ethical procedures were based on the Brazilian law
6638 (May 8, 1979) ‘Normas para Pra´tica Dida´tico-
Cientı´fica da Vivissecc ¸a ˜o de Animais’, which is in accor-
dance to the ‘European Convention for the Protection of
Vertebrate Animals used for Experimental and Other
Scientific Purposes’ (Strasbourg, March 18, 1986).
Moribund rats were sacrificed for humane reasons, by
deep anesthesia.
Comfrey Extract Preparation
One kilogram of Comfrey leaves harvested from FCAV –
Campus Jaboticabal (SP - Brazil) during the winter (July,
in Brazil) was soaked with 1l of 93% ethanol and left to
stand for 10 days at room temperature (253C). After
this period, the mixture was filtered through conventional
filter paper and processed by evaporation methods to
obtain the ethanolic extract.
Experimental Groups
The 10% Comfrey extract was administered to all
groups, three times a week, in a volume of 0.02ml/kg
1
body weight, throughout all the experimental period.
This extract concentration was chosen to reproduce the
popular method of leaf preparation where toxic effects
are described (11). Each group (N=20at the beginning
of the study) received the treatment by gavage, being the
control treated with distilled water and the experimental
group treated with the distilled water diluted extract.
Deaths are common in RHM and the rats that died
during the study were not analyzed. At the end of the
study, the number of surviving rats was eight in the
control group and nine in the experimental group.
The carcinogenesis protocol was as illustrated in the
following scheme:
Day of
experiment
Zero 15–17 18 20,22 30
Phase of
carcino-
genesis
Initiation Initiation Promotion Initiation –
Procedure Inoculation Inocula-
tion
Hepatectomy
(30% of the
liver mass)
Inocula-
tion
Sacrifice
Substance DEN 2AAF – 2AAF –
Dose 300mg/kg
(intra-
peritoneal)
20mg/kg
(gavage)
– 20mg/kg
(gavage)
–
DEN, N-nitrosodiethylamine (SIGMA, St Louis, USA); diluted in 0.9%
NaCl; 2AAF, 2-acetilaminofluorene (SIGMA, St Louis, USA); diluted
in corn oil.
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adapted from Dagli and colleagues (29). All carcinogenic
substances were handled in a chamber with controlled air
output. All personnel involved wore appropriate masks
provided with filters against powder and volatile sub-
stances, security glasses and double gloves. All material
used for injections or gavage was discarded in
appropriate boxes for hazardous specimens.
Macroscopic Analysis
After sacrifice, the number of PNLs on the liver surface
was counted and classified according to diameter:
(i) <1mm, (2) around 1mm and (3) >1mm.
Microscopic Analysis
One 5mm thick central slice was harvested from the left
lateral lobe of the liver and fixed in Carnoy solution
(3:1:6 chloroform: glacial acetic acid: absolute alcohol)
for 4h (30). This material was processed by routine
histological methods and stained with hematoxylin–eosin,
Ag–nucleolus organizing regions (NOR), Masson’s tri-
chrome and periodic acid Schiff (PAS). The immunohis-
tochemistry procedures were also made from the same
paraffin embedded material.
To perform the histometry of cell types and mitotic
figures, photomicrographs of 5 pre-determined fields
(top, bottom, laterals and center of the fragment) of
each liver slice were obtained using a 200 objective.
A grid with 200 points printed on transparent film was
superimposed on the photographs and the number of
points of intersection incident on each structure was
recorded. The structures counted were: oval cells (hepatic
steam cells), non-megalocytic and megalocytic hepato-
cytes (including multinucleated hepatocytes), degenerated
(vacuolized) cells and mitotic figures (including typical
and atypical mitosis).
PNLs were classified as ‘acidophilic’, ‘mixed’ and ‘clear’
patterns (29) and the total PNLs of each type per slice
was counted directly from the microscope (Alphaphot,
Nikon, Japan). Fibrosis was scored as follows, on the
basis of Masson trichrome staining:
SCORE 0: without evidence of fibrosis
SCORE 1: discrete peri-portal fibrosis
SCORE 2: peri-portal and inter-nodular fibrosis
SCORE 3: peri-portal and inter-nodular fibrosis and
capsule thickening
The same scoring method was used to quantify
glycogen content of liver cells by PAS staining, as
follows:
SCORE 0: without granules
SCORE 1: weak and diffuse granulation
SCORE 2: strong and multifocal granulation
SCORE 3: strong and diffuse granulation
Complementary slides were prepared for AgNOR
protein identification using a silver staining method and
for PCNA labeling by immunohistochemistry. The NORs
were counted as described by Zaczek and colleagues (30).
The number of NORs present in histological preparations
reflects the quantity of active ribosomal genes and thus
the proliferating status of tissues. This method is
adequate to verify early stages of cell proliferation,
including the interphase of the cell cycle, before the
formation of mitotic figures.
The Proliferating Cell Nuclear Antigen (PCNA) posi-
tive cells counting was performed by submitting the slides
to hot high pressure followed by overnight incubation
with 1:100 anti-PCNA antibody (mouse anti-human,
PC-10 clone, DAKO). The LSAB amplification system
was also used. The slides were back stained with
hematoxylin. Five microscopic fields were randomly
chosen and 500 cells were counted for each slide. The
PCNA method reveals the ‘S phase cycle’ positive cells, it
means, cells in the early stages of duplication. Positive
cells presented strongly nuclear reactivity. The numbers
of positive and negative cells were recorded.
All the quantification procedures were done in blind.
Statistical Analysis
F-test to compare variances was first performed to verify
the Gaussian distribution of the variables, as a result of
which non-parametric Mann–Whitney tests (PNL, NOR,
fibrosis and glycogen granules counting) and 
2-test
(cell counting) were used. The ‘P’ values were fixed at
P0.05.
Results
Macroscopic Pre-neoplastic Nodules Counting
PNL counting on the liver surface is represented in
Fig. 1. The number of nodules measuring 1mm in
diameter or less was significantly reduced in Comfrey
treated rats, compared to control.
Microscopic Morfometry
The cell type percentages are given in Table 1. The
experimental group showed significant increase in the
percentage of megalocytic and vacuolized cells and
decrease in oval cells, PCNA positive cells and mitosis,
compared to control.
The number of NORs per field and the scores for
fibrosis and glycogen granulation on liver slides, respec-
tively stained by Masson trichrome and PAS, did not
eCAM 2010;7(2) 199differ between groups. Table 2 shows the number of PNL
according to nodule classification. The experimental
group presented significant reduction of acidophilic
nodules compared to control.
In short, the results showed a clear protective effect of
Comfrey extract on the early stages of induced hepatic
carcinogenesis.
Discussion
In this work, the putative effects of Comfrey extract on
the initial stages of neoplastic development were tested.
Both, macroscopic and microscopic criteria were con-
sidered to evaluate its capacity to change proliferation
parameters.
Macroscopically, the number of PNLs was reduced by
treatment with Comfrey extract, mainly those measuring
1mm or less. This particular result suggests that Comfrey
extract was able to modulate the early stages of PNL
development. These macroscopic findings were supported
by the microscopic observations. The increase of the
percentage of megalocytic and vacuolized liver cells,
associated with the decrease of the percentage of oval
cells, PCNA—positive cells, mitotic figures and the
number of acidophilic nodules, converge to the anti-
proliferation hypothesis. Considering the cell phenotype,
the pre-neoplastic nodules are classified according to the
following aggressiveness indicators: clear (vacuolized/
degenerated) cells, mixed (acidophilic and vacuolized
cells in the same nodule) cells, acidophilic (intense protein
synthesis) cells and basophilic (intense proliferation
activity) cells.
It is important to note that oval cells and acidophilic
nodules are typical manifestations of early tumor estab-
lishment (29). Thus, their reduction also points toward to
a qualitative anti-neoplastic property.
Adding to the earlier described findings, the increase of
megalocytosis percentage, the decrease of PCNA-positive
cells and cells showing mitosis phenotype also suggest
anti-mitotic effects. Some authors consider megalocytosis
as a ‘frustrated mitosis’, in which the cell prepares to
divide but telophase does not occur (31). This phenotype
has been described by other authors in liver models,
especially those associated with the effects of pyrrolizi-
dine alkaloids (32), also present in Comfrey extracts
(14, 33–35). It is known that chronic ingestion of
pyrrolizidine alkaloids by cattle leads to peri-portal
fibrosis and bile duct proliferation (33), phenomena
related to the proliferation of oval cells. Herein, the
reduction on the percentage of these cells reinforces the
evidence of anti-mitotic effects (36).
This convergence of results is according the previous
studies in which the anti-mitotic effects of pyrrolizidine
alkaloids are preponderant over the carcinogenic ones in
short-term experimental procedures (37).
The negative result of AgNOR counting may be related
to the low degree of sensitivity of this test.
Although scores of glycogen cell stores were not
modified, vacuolized hepatocytes were more numerous
0
50
100
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comfrey
* #
Figure 1. Total number of pre-neoplastic lesions (PNL) counted on the
surface of livers of rats undergoing the ‘resistant hepatocyte’ model.
Values represent the total number of nodules in all animals;
experimental rats were treated with 10% Comfrey extract, po.
*Mann–Whitney test, P=0.0464 (U=57.000);
#Mann–Whitney test,
P=0.0037 (U=65.000).
Table 1. Histometry data: percentage of points corresponding to each
structure observed in photomicrographs of livers from rats undergoing
the ‘resistant hepatocyte’ model
Structures counted Control (%) Experimental (%)
Megalocytic cells 7.88 11.11
##
Non-megalocytic cells 55.4 64.95
Oval cells 34.24 19.20
#
Vacuolized cells 1.68 4.31
##
Mitotic figures 0.80 0.43*
PCNA positive cells 13.86 5.13**
Total 100 100
Experimental rats were treated with 10% Comfrey extract, po.
*
2=12.226; P=0.0005;
#
2=6.949; P=0.0084;
##
2=364.86;
P<0.0001; **
2=65.523; P<0.0001.
Table 2. Histometry data: Number of pre-neoplastic lesions (PNLs) per
slice defined as: ‘acidophilic’, ‘mixed’ or ‘clear cell’ nodules
PNL Control (N=8) Experimental (N=9)
Acidophilic cells 7.8714.31
a 2.115.97**
Mixed 28.3723.86 11.0014.26
Clear cells 1.502.390 1.882.571
Experimental rats were treated with 10% Comfrey extract, po.
aValues represent meanstandard deviation.
**Mann–Whitney test, P=0.05 (U=56.0).
This cell behavior follows the sequence: clear/mixed/acidophilic/
basophilic nodules, according to their aggressiveness (see text).
200 Comfrey and carcinogenesisin treated rats, what could be related to some oxidative
toxic effects of Comfrey (36). In fact, degenerative
hepatocyte lesions induced by this plant have been
described previously (18, 19). The study of Comfrey
and other herbs largely used as complementary medicine
deserves more specific studies, since plant extracts
are chemically diverse and may be able to modulate
several metabolism steps simultaneously. Nowadays,
some gene expression studies are on the focus of scientific
interest for better understanding their molecular mechan-
isms (38).
To delineate a general hypothesis about the putative
mechanism of action of Comfrey extract in this model, a
resumed framework is presented in the Fig. 2, showing
how the mitotic process could be suppressed at several
steps, at the same time.
In conclusion, the present findings can contribute to
understand a very particular and under explored Comfrey
pharmacological activity, since the treatment of rats with
its extract seems to protect them from early development
of pre-neoplastic liver lesions, by inhibiting cell prolifera-
tion and modulating atypical phenotype.
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